Global fear of Ebola outbreak stokes a frenzy of new R&D | Air Force Secretary doubles down on nuclear mission | Analysis of chemicals relevant to the Chemical Weapons Convention | Marburg drug shows promise | Harnessing the power of convalescents for severe viral infections | Ebola puts focus on drugs made in tobacco plants | Why are so many women dying from Ebola? | Assessing FDA’s final guidance on companion diagnostics | 4th MEB trains for disaster on the homefront | Chikungunya vaccine clears Phase 1 | Treatment in U.S. rare chance to study Ebola | Seals infected early Americans with tuberculosis | Ebola crisis: Ivory Coast closes land borders | Plants and their growing role in the pharmaceutical industry | Confronting biological plagues like Ebola, smallpox, and anthrax | WHO: Ebola outbreak underestimated | Containing the international spread of Ebola | Large trial finds high-dose flu shot beneficial for seniors| Those who serve Ebola victims soldier on

See what we’re reading this week at Global Biodefense on plant-based vaccines, chemicals relevant to the Chemical Weapons Convention, Chikungunya vaccine and more…

Global fear of Ebola outbreak stokes a frenzy of new R&D (Fierce Biotech)

Air Force Secretary doubles down on nuclear mission (Defense One)

Marburg drug shows promise (The Scientist)

Analysis of chemicals relevant to the Chemical Weapons Convention (Springer Link)

Harnessing the power of convalescents for severe viral infections (UPMC CBN)

Ebola puts focus on drugs made in tobacco plants (Seattle Times)

Why are so many women dying from Ebola? (Foreign Policy)

Assessing FDA’s final guidance on companion diagnostics (MDT)

4th MEB trains for disaster on the homefront (DVIDS)

Chikungunya vaccine clears Phase 1 (The Scientist)

Treatment in U.S. rare chance to study Ebola (NY Times)

Seals infected early Americans with tuberculosis (Science)